Petition to EMA for Stay of Pfizer COVID-19 Vaccine Trial Phase III

This petition for a stay of action is submitted by the undersigned (“ Petitioner ” or “ Lead
Petitioner ”) to request the EMA a) stay the Phase III clinical trial(s) of BNT162b (EudraCT
 Number 2020-002641-42) in the EU (current protocol country: Germany) until study design is
amended to conform with the requests in the “Action Requested” section ( B. ) below; and b) stay
all other clinical trials of vaccine candidates designed to stop transmission of the virus from the
vaccine recipient to others and/or prevent or mitigate symptoms of COVID-19 for which PCR
results are the primary evidence of infection.

Because of the compelling need to ensure the safety and efficacy of any COVID-19 vaccine
licensed by the EMA (and/or the German Paul-Ehrlich-Institut), and to allow Petitioner the
opportunity to seek appropriate emergency judicial relief should the EMA deny its Petition,
Petitioner respectfully requests that EMA act on the instant Petition immediately.